The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic role of lymphocyte to monocyte ratio in patients treated with CAR-T for aggressive lymphoma.
 
Henan Zhang
No Relationships to Disclose
 
Radhika Bansal
No Relationships to Disclose
 
Kodi Peterson Martinez
No Relationships to Disclose
 
Matthew Hathcock
No Relationships to Disclose
 
Zuoyi Shao
No Relationships to Disclose
 
Gabriele McCoy
No Relationships to Disclose
 
Anatilde Gonzalez-Guerrico
No Relationships to Disclose
 
N. Nora Bennani
Consulting or Advisory Role - Daiichi Sankyo; Kyowa Kirin
 
Jonas Paludo
Research Funding - Verily (Inst)
Other Relationship - Jazz Pharmaceuticals (Inst)
 
Yucai Wang
Consulting or Advisory Role - Loxo (Inst)
Research Funding - Genentech (Inst); Incyte (Inst); InnoCare (Inst); Novartis (Inst)
 
Patrick Johnston
No Relationships to Disclose
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - ADC Therapeutics (Inst); Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)
 
Saad Kenderian
No Relationships to Disclose
 
Luis F. Porrata
No Relationships to Disclose
 
Jose Caetano Villasboas
Consulting or Advisory Role - Kite/Gilead (Inst); Regeneron (Inst)
 
Yi Lin
Consulting or Advisory Role - Bluebird Bio (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Gamida Cell (Inst); Janssen Oncology (Inst); Juno Therapeutics (Inst); Kite/Gilead (Inst); Legend Biotech (Inst); Novartis (Inst); Sorrento Therapeutics (Inst); Vineti (Inst)
Research Funding - Bluebird Bio (Inst); Boston Scientific (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Janssen Oncology (Inst); Kite/Gilead (Inst); Merck (Inst); Takeda (Inst)